PHGE Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Valuation Metrics

The current forward P/E ratio for Biomx Inc (PHGE.A) is -0.15, compared to its 5-year average forward P/E of -1.39. For a more detailed relative valuation and DCF analysis to assess Biomx Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-1.39

Current PE

-0.15

Overvalued PE

-0.02

Undervalued PE

-2.76

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-0.56

Current EV/EBITDA

-0.58

Overvalued EV/EBITDA

0.38

Undervalued EV/EBITDA

-1.50

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

13.94

Current PS

0.00

Overvalued PS

62.33

Undervalued PS

-34.45

Financials

Annual

Quarterly

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

PHGE News & Events

Events Timeline

No data

News

8.5

2025-12-29Globenewswire

BiomX Secures $3 Million in Private Placement to Advance Phage Programs

8.5

2025-12-29Newsfilter

BiomX Secures $3 Million in Private Placement to Advance Phage Programs

9.0

2025-12-09NASDAQ.COM

BiomX Suspends Phase 2b Trial of BX004 for Cystic Fibrosis Due to Elevated Adverse Event Rates

People Also Watch

Frequently Asked Questions

What is Biomx Inc (PHGE) stock price today?

The current price of PHGE is 2.18 USD — it has decreased -2.68 % in the last trading day.

What is Biomx Inc (PHGE)'s business?

BiomX Inc., formerly Chardan Healthcare Acquisition Corp., is a microbiome company. The Company is focused on developing both natural and engineered phage therapies. It develops therapies to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease (IBD), primary sclerosing cholangitis (PSC) and cancer. The Company discovers and validates bacterial targets and customizes phage compositions against the targets. Its pipeline includes BX001, BX002 and BX003. BX001 is a product candidate that improves the appearance of acne-prone skin. BX002 is a customized phage cocktail that eradicates bacterial targets associated with the onset of IBD. BX003 is a customized phage cocktail developed against specific strains of Klebsiella pneumoniae (Kp).

What is the price predicton of PHGE Stock?

Wall Street analysts forecast PHGE stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for PHGE is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Biomx Inc (PHGE)'s revenue for the last quarter?

Biomx Inc revenue for the last quarter amounts to -8.54M USD, decreased -18.91 % YoY.

What is Biomx Inc (PHGE)'s earnings per share (EPS) for the last quarter?

Biomx Inc. EPS for the last quarter amounts to -7185000.00 USD, decreased -11.37 % YoY.

What changes have occurred in the market's expectations for Biomx Inc (PHGE)'s fundamentals?

The market is revising No Change the revenue expectations for PHGE for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -81.49%.

How many employees does Biomx Inc (PHGE). have?

Biomx Inc (PHGE) has 52 emplpoyees as of January 09 2026.

What is Biomx Inc (PHGE) market cap?

Today PHGE has the market capitalization of 3.30M USD.